Blue Horseshoe Stocks

ATRN, ARNA & Today’s Extended Watchlist

Atrinsic, Inc. ATRN

ATRN is a stock we have been covering for quite some time. Some of you may recall the huge run exhibited by the stock earlier this year. Following our alert in January, the stock was trading as low as .012, only to hit a high of .3599 by February for one of our biggest gains all year, totaling 2899% .

As for the present situation, the stock has not been this low since January, and while we do not expect a run of the magnitude we saw before, even a run to the 50DMA of .07, from this level would yield a gain of 100%

We’d like to see the stock hold its key level of support .035, and are looking for a break past .05 (20DMA), which is the first main area of resistance.

____

Arena Pharmaceuticals, Inc. ARNA

ARNA continues to pile up the gains since we began mentioning it back on May 11th , having risen a total of 53% since that time.

We said that the time leading up to the company’s prosposed FDA approval date of 06/27 was going to be interesting, and we were correct. The stock continues to run as we approach zero hour, and we are certainly excited to see the results, and how the stock is affected at that time.

____

Extended Watchlist:

XG (Coming off lows), WEST, ICPA, THWI,

THWI, ENTB & Today’s Extended Watchlist

Thwapr, Inc. THWI

THWI dipped as low as .0315 on Thursday, and bounced back to close at .0364. That adds up to a 16% intraday gain.

The stock held above its 20DMA. This week’s consolidation pattern does not threaten our opinions of THWI, as the price movement has been on relatively light volume. Once we see a pickup in volume, we should see some positive moves. We think this could happen as soon as next week.

Barchart is currently giving THWI a “Buy” Rating

____

Entest BioMedical Inc. ENTB

ENTB has been on one heck of a run of late. We are expecting such a play to show some consolidation after making such big moves (almost 1400% in the past month), and will be observing for this to occur.

Generally, a stock that has displayed these kinds of gains over a relatively short period are in for a bit of a slide; something that is generally followed up by a bounce. That is what we will be awaiting.

____

Extended Watchlist:

JASO, VPER, EEGC,

IBIO, ARNA, & Today’s Extended Watchlist

iBio, Inc. IBIO

We’ve been quietly watching IBIO for quite some time. This AMEX stock has been on a consistant downtrend for the past couple of months, and is reaching the point where we felt it was time to begin sniffing for a bottom.

As you can see from the chart below, IBIO has the look of a stock that could be in for quite a recovering run once that ultimate bottom is reached. Shares from this price level could really turn out to be a bargain in the long run.

_____

Arena Pharmaceuticals, Inc. ARNA

ARNA hit a high of 8.65 on Wednesday. That’s a 57% gain from the stock’s low (5.50) following our initial alert. It appears that many investors are, like us, highly anticpating the possibility of ARNA’s FDA Approval.

We’ve already seen sizable gains from ARNA, and certainly would like to keep the stock on our radars for the forseeable future. We will, of course, keep you updated as to the situation.

____

We’d like to congratulate any traders who managed to trade RGIN successfully yesterday, as it was not for the faint of heart. The stock opened at .285 yesterday, and hit a high of .44 before falling into the close at .20. Savvy traders could still have made an intraday gain of 54% early on, and if anyone caught the afternoon bounce from .151 to .249 that came following the high of day, an additional 62% gain was possible.

____

Extended Watchlist:
JASO, VPER, THWI, OMVE

THWI, OMVE & Today’s Extended Watchlist

Thwapr, Inc. THWI

Within the past month, THWI has exploded 1336% from .0055 to .079. The stock ran into resistance at the 200DMA. After such a surge, consolidation, which we’ve been seeing over the past couple of weeks, is to be expected.

THWI has been maintaining support above the 20DMA, and has made higher lows for the past five sessions. To us, that seems like a recipe for another possible breakout.

Apart from a nice chart setup, the company has had a slew of PR’s over the past few weeks that we’ve linked to below. We’ve also included a video chart for your convenience.

Recent Press:

Thwapr Executes on Channel Partner Strategy in Asia -06/11

Thwapr to Localize Its iPhone App for China -06/04

Thwapr Takes Steps to Protect Its Patent-Pending Technology in China -05/31

Thwapr, Inc. Provides Corporate Update on Asia Progress and Asian Outlook -05/29

_____

Omni Ventures, Inc. OMVE

Having seen higher lows for four consecutive sessions following a bounce off of its bottom, OMVE is another play that we dug up in our search for new blood.

Our penny-sense is starting to tingle, as all the chart indicators seem to be ripening up. We’ve generally observed, that once a stock moves past its 200DMA, a breakout often follows. That said, we’re looking at .22 (200DMA) as the next key area of resistance.

We’ve provided you with a video chart for OMVE as well:

____

We also wanted to congratulate anyone who was able to take advantage of our calls from yesterday’s report. Both YIPI and ARNA enjoyed solid performances during yesterday’s trading. Both stocks closed near their high-of-day on abnormally high volume.

____

Extended Watchlist:

RGIN, VPER,

YIPI, ARNA & Today’s Extended Watchlist

Yippy, Inc. YIPI

YIPI recently caught our attention, as a stock that has been on a steady incline for months now. Yesterday’s activity was exciting, and despite the Dow being down over 100 points, YIPI managed a nearly 60% gain.

Any stock that is doing this well during a relatively turbulent time is certainly worth a second look.

The company also had some news out yesterday:

Yippy, Inc. (YIPI) and MuseGlobal to Merge, Offering Unified Access to a Data Cloud of Curated Content

http://www.yippy.com

____

Arena Pharmaceuticals, Inc. ARNA

This stock has appeared on our newsletters before. On May 11th, we stated that “we want to watch this play carefully heading into the month of June, being the target month for FDA approval, as we believe that there could be trading opportunities in the meantime”

We turned out to be correct. In the days following our alert, the stock was trading as low as 5.50, and yesterday reached a high of 7.23, for a 31% gain. Should the company indeed receive the FDA approval it seeks, that 31% could be just a drop in bucket of some much larger gains.

We will keep our eyes peeled for any additional press coming over the wires. In the meantime here’s a link to this morning’s announcement:

Arena and VIVUS Race to Be the First in the Lucrative Anti-Obesity Drug Market

____
Extended Watchlist:

EEGC, CLNO